je.st
news
Tag: prostate
Micro-Ultrasound System supports prostate imaging and biopsy.
2015-05-21 14:31:07| Industrial Newsroom - All News for Today
Enabling 29 MHz micro-ultrasound imaging, ExactVu™ will help urologists clearly visualize and target suspicious transrectal regions for biopsy, as well as perform systematic biopsy protocols. System also supports conventional probes and frequencies for routine imaging applications such as trans-abdominal and other urological procedures.
Tags: system
supports
imaging
prostate
Mark Carnegie-backed biotech Minomic creates improved prostate cancer test
2015-04-20 04:30:55| Biotech - Topix.net
Minomic CEO Brad Walsh says the company's new prostate cancer test could be on sale before the end of the year. Biotechnology company Minomic has developed a simpler, more accurate blood test for diagnosing prostate cancer, which could reduce the number of men who go onto invasive follow up tests and suffer plenty of heartache after receiving an initial 'false positive' result.
Tags: test
mark
improved
cancer
Advaxis and Merck Announce Initiation of Enrollment in the Phase 1/2 Study of ADXS-PSA in Combination with Anti-PD-1 Therapy, KEYTRUDA (pembrolizumab), for the Treatment of Advanced Prostate Cancer
2015-04-08 13:30:05| Merck.com - Product News
Dateline City: PRINCETON, N.J., and KENILWORTH, N.J. KEYNOTE-046 is the second trial initiated to evaluate KEYTRUDA, and the first-in-human study of ADXS-PSA, for prostate cancer Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, and Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced that enrollment has initiated in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA (ADXS31-142), an investigational Lm-LLO immunotherapy, and KEYTRUDA (pembrolizumab), the first anti-PD-1 (programmed death receptor-1) therapy approved in the United States, in patients with previously treated, metastatic castration-resistant prostate cancer (mCRPC). Language: English read more
Advaxis, Merck to test immune therapies against prostate cancer
2014-08-25 12:19:09| Biotech - Topix.net
Advaxis Inc on Monday said it will test an experimental immuno-oncology drug in combination with a high-profile immunotherapy from Merck & Co Inc as a treatment for patients with advanced prostate cancer.
Tags: test
cancer
immune
therapies
Generex Biotechnology Corporation Announces Publication Of AE37 Prostate Cancer Vaccine Study
2014-08-07 12:18:56| Biotech - Topix.net
The study demonstrates an association between a specific immune response generated by AE37 and improved overall survival.
Tags: study
publication
corporation
cancer